Structure-Tissue Exposure/Selectivity Relationship (STR) on Carbamates of Cannabidiol.

Area of Science:

• Pharmacology
• Medicinal Chemistry
• Drug Discovery

Background:

• The structure-tissue exposure/selectivity relationship (STR) is crucial for optimizing drug candidates, balancing dose, efficacy, and toxicity.
• Cannabidiol (CBD) carbamates targeting butyrocholinesterase (BuChE) were employed to investigate STR in relation to efficacy and toxicity.

Purpose of the Study:

• To explore the correlation between STR and observed efficacy/toxicity using novel CBD carbamates.
• To understand how structural modifications influence drug pharmacokinetics, tissue exposure, and selectivity.

Main Methods:

• Synthesis and evaluation of CBD carbamates with varying structures.
• Pharmacokinetic studies to assess plasma and brain exposure.
• Correlation analysis between tissue exposure/selectivity and efficacy/safety profiles.
• Assessment of metabolic stability of carbamate functional groups.

Main Results:

• CBD carbamates with similar structures and targets exhibited varied pharmacokinetic profiles.
• Plasma exposure of L2 and L4 was similar but not predictive of brain exposure; however, tissue exposure/selectivity correlated with efficacy/safety.
• Structural changes in CBD carbamates modulated both plasma and tissue exposure/selectivity.
• Secondary amine carbamates were metabolized to CBD, while tertiary amines showed greater stability.

Conclusions:

• STR significantly influences drug efficacy and safety by altering tissue exposure in normal tissues.
• Absorption, distribution, metabolism, excretion, and toxicity (ADMET) parameters can predict STR.
• Balancing structure-activity relationship (SAR) and STR is essential for successful drug candidate optimization and improved clinical trial outcomes.